Stoke Therapeutics Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi STOK
Stoke Therapeutics bases its future revenue on RNA technologies to combat Dravet syndrome. The development of treatments for epilepsy and vision pathologies reduces scientific risks, while success in brain therapy makes the company independent of macroeconomic factors. By comparing the absolute EBITDA dynamics on GURU.Markets, we see that 0.00 reflects the latest level of the metric, revealing the real cash resilience of the business.
Ringkesan rincian data analitis Stoke Therapeutics, Inc. (STOK)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- informasi kapitalisasi buku:
- indikator total utang lan likuiditas perusahaan:
Utang marang Modal Stoke Therapeutics|STOK - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Stoke Therapeutics Inc|STOK - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Stoke Therapeutics|STOK - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Stoke Therapeutics|Likuiditas darurat stoketherapeutics.com
- rincian asil keuangan lan kelipatan valuasi:
STOK - Penghasilan resik|Proyeksi bathi mangsa ngarep Stoke Therapeutics|STOK - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep stoketherapeutics.com|STOK - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Stoke Therapeutics|STOK - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Stoke Therapeutics|STOK - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan stoketherapeutics.com|STOK - Wutah bathi saben saham ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Stoke Therapeutics
Ringkesan analitik perusahaan:STOK (Stoke Corp)
This metric reflects the daily volume of operating cash flow before taxes and interest. It measures the business's actual ability to generate cash from its core operations. By analyzing operating profit in cash terms, an investor assesses the current financial stability of the asset. For Stoke Therapeutics (STOK), this metric demonstrates the efficiency of monetizing patents in the field of gene therapy. Steady growth of this indicator confirms the commercial potential of unique drugs.
Pesaing Stoke Therapeutics (STOK)
Tempus (TEM) - Bathi sadurunge bunga, pajak, lan amortisasi|QGEN: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi IONS (ionispharma.com)|RGEN (Repligen) - Bathi operasional sadurunge ngurangi amortisasi|RNA: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|CRSP (CRISPR Therapeutics Corp) - Bathi operasional EBITDA|WGS: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA RARE|BEAM - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sarepta SRPT|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TWST|10x Genomics Corp - Bathi operasional EBITDA|NTLA - Bathi operasional EBITDA|BioLife Solutions, Inc. (BLFS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi WVE (wavelifesciences.com)|MAZE (Maze Therapeutics) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Sionna Therapeutics, Inc. SION|Bathi operasional sadurunge ngurangi amortisasi PRME (Prime Medicine Corp)|Bathi operasional EBITDA Taysha Corp (TSHA)|uniQure N.V. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MGTX (meiragtx.com)|REGENXBIO - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Solid Biosciences Inc SLDB|OCGN: Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi PacBio Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Benitec Biopharma Inc.|designtx.com (DSGN) - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Rocket Pharmaceuticals, Inc. (RCKT)|Pendapatan operasional sadurunge ngurangi amortisasi 4DMT|Lexeo Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi KRRO (Korro Bio Inc.)|EDIT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi silence-therapeutics.com|proqr.com (PRQR) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Codexis (CDXS) - Bathi operasional EBITDA|SGMO (Sangamo) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi NAUT (Nautilus Biotechnology Inc)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Metagenomi, Inc. (MGX)|precisionbiosciences.com - Bathi operasional sadurunge amortisasi|Bathi operasional EBITDA GBIO (Generation Bio)|Bathi operasional EBITDA Boundless Bio Inc. BOLD|XCUR - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Imunon, Inc. IMNN|PHIO (phiopharma.com) - Bathi operasional sadurunge ngurangi amortisasi|MBIO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics Inc.|Bathi sadurunge bunga, pajak, lan amortisasi Bionano BNGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Applied DNA (APDN)|Bathi operasional EBITDA bluebird bio, Inc (BLUE)|Bathi operasional EBITDA IPA (ImmunoPrecise Antibodies Ltd.)|omegatherapeutics.com (OMGA) - Bathi sadurunge bunga, pajak, lan amortisasi|OMIC: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi RGLS (Regulus Therapeutics, Inc.)|SYRS (Syros) - Bathi operasional sadurunge ngurangi amortisasi|TBIO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|TCON (TRACON Pharmaceuticals) - Bathi operasional EBITDA|UBX: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi
